お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
925508

眼科用超音波装置市場:成長、動向、予測(2020~2025)

Ophthalmic Ultrasound Systems Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.74円
眼科用超音波装置市場:成長、動向、予測(2020~2025)
出版日: 2020年02月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

眼に関連する疾患の有病率の上昇は、世界的に眼科超音波の需要の増加につながっています。多くの先進国と発展途上国では、目の状態が人口に対する潜在的な脅威として浮上しています。さまざまな国で糖尿病の有病率が増加しているため、糖尿病性網膜症が優先リストに追加されています。緑内障は、その早期診断が困難であり、生涯にわたり治療が頻繁に必要であるため、公衆衛生の課題が残っています。 WHOによると、2018年には、約13億人が何らかの形の視覚障害を抱えて生活していたと推定されています。

市場の成長要因である、世界中で眼疾患の負担が増大していることを示しています。

当レポートでは、眼科用超音波装置市場を調査し、市場概要、市場の成長要因および阻害要因の分析、製品別・モダリティ別・エンドユーザー別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概要
  • 市場成長要因
    • 眼疾患の有病率の増加
    • 新しい眼科技術の登場
    • 政府別公衆衛生意識向上プログラムの台頭
  • 市場の抑制要因
    • 他の診断ツールの進歩と採用の増加
    • 厳格な政府規制
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 競争の激化

第5章 市場細分化

  • 製品別
    • スキャン
    • B-スキャン
    • 複合スキャン
    • 厚度計
    • 超音波バイオ顕微鏡(UBM)
  • モダリティ別
    • ポータブル
    • スタンドアロン
  • エンドユーザー別
    • 病院
    • 眼科クリニック
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Appasamy Associates
    • DGH Technology Inc.
    • Ellex Medical Lasers Ltd
    • Micro Medical Devices
    • NIDEK CO., LTD.
    • Optos PLC (Nikon Corporation)
    • Quantel Medical
    • Reichert Inc.
    • Sonomed Escalon

第7章 市場機会および将来動向

目次
Product Code: 64423

The rising prevalence of eye-related diseases is leading to increased demand for ophthalmic ultrasound, globally. In many developed and developing countries, eye conditions have emerged as potential threats to the populations. The increase in the prevalence of diabetes in various countries has led to the addition of diabetic retinopathy to the priority list. Glaucoma, an eye disease known for centuries, remains on the public health agenda due to difficulties in its early diagnosis and the frequent necessity for life-long treatments. According to WHO, in 2018, it was estimated that approximately 1.3 billion people lived with some form of vision impairment, while 188.5 million people had mild vision impairment, 217 million had moderate to severe vision impairment, and 36 million people were blind.

Globally, the leading causes of vision impairment are uncorrected refractive errors and cataracts, and most people with vision impairment are over the age of 50 years. According to WHO, chronic eye diseases are the number one cause of vision loss, with the top two causes being unoperated cataracts and uncorrected refractive errors. The former is the leading cause in countries with low or middle incomes.

Hence, the above-mentioned statements indicate that there is a growing burden of eye diseases across the globe which is a fuelling factor for the growth of the market studied.

Key Market Trends

B-Scan to Hold a Significant Share of the Market

B-Scan or Brightness Scan provides a two-dimensional cross-sectional view of the eye. It is used on the outside of the closed eyelid. When examination of eye normally is difficult, B-scan is used. There are certain abnormalities of the eyes that make a routine examination difficult which include edema or tarsorrhaphy or severe cataracts and keratoprosthesis. A B-scan helps in accurately viewing other eye structures such as the lens, choroid, sclera, vitreous and retina. A B-scan is helpful in diagnosing retinal detachment. A B-scan is often a tool combined with an A-scan to help determine various eye abnormalities. With such advantages of a B-Scan, it is widely used across the globe and companies are coming up with the novel and technologically advanced B-scans which is fuelling the demand for the same.

North America Dominates the Market and Expected to do Same in the Forecast Period.

Factors such as high disposable incomes, high awareness, rising geriatric population, and the prevalence of eye diseases, are fueling the growth of the market studied in the North America region especially in the United States. As per the report by the US Centre of Disease Control and Prevention, there were about 40.9 million wearers of contact lenses aged 18 or older, which accounted for about 16.7% of the adult population in the United States, in 2015. National Eye Institute estimated that over 2.9 million American residents were detected with low vision, in 2014. The number is projected to increase further and is expected to reach around 5 million by 2030.

Hence, owing to the rising prevalence of eye diseases and the presence of the key market players in the region, North America is dominating the market studied.

Competitive Landscape

  • The majority of the ophthalmic ultrasounds are being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market.
  • Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Eye Diseases
    • 4.2.2 Advent of Novel Ophthalmic Technologies
    • 4.2.3 Rise in Public Health Awareness Programs by Government
  • 4.3 Market Restraints
    • 4.3.1 Increasing Advancement and Adoption of Other Diagnostic Tools
    • 4.3.2 Rigorous Government Regulations
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 A- Scan
    • 5.1.2 B- Scan
    • 5.1.3 Combined Scan
    • 5.1.4 Pachymeter
    • 5.1.5 Ultrasound Bio-microscopy (UBM)
  • 5.2 By Modality
    • 5.2.1 Portable
    • 5.2.2 Standalone
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ophthalmology Clinics
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 COMPANY PROFILES
    • 6.1.1 Appasamy Associates
    • 6.1.2 DGH Technology Inc.
    • 6.1.3 Ellex Medical Lasers Ltd
    • 6.1.4 Micro Medical Devices
    • 6.1.5 NIDEK CO., LTD.
    • 6.1.6 Optos PLC (Nikon Corporation)
    • 6.1.7 Quantel Medical
    • 6.1.8 Reichert Inc.
    • 6.1.9 Sonomed Escalon

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.